Illumina Names Philip W. Schiller to its Board of Directors
Get Alerts ILMN Hot Sheet
Join SI Premium – FREE
SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) announced today that Philip W. Schiller has joined the company’s Board of Directors. Schiller is currently Apple’s Senior Vice President of Worldwide Marketing and is a member of Apple’s executive team responsible for the company’s product marketing, developer relations, business marketing, education marketing, international marketing and App Store programs.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160728005475/en/
Philip W. Schiller (Photo: Business Wire)
Since rejoining Apple in April 1997, Schiller has helped the company create and market some of the best-selling products in the world including the Mac, iPod, iTunes, iPhone, the App Store, Apple TV and the Apple Watch.
“Phil’s track record and global experience in bringing world-class products to market will help guide us as we continue to develop innovative new solutions for our customers,” said Francis deSouza, Illumina President and Chief Executive Officer. “His vision, integrity and passion are fully aligned with Illumina’s core values.”
Schiller has more than 30 years of marketing and management experience, including over 25 at Apple in various marketing positions; as the Vice President of Product Marketing at Macromedia, Inc. of San Francisco, Calif.; as the Director of Product Marketing at FirePower Systems, Inc. of Menlo Park, Calif.; as an Information Technology Manager at Nolan, Norton & Company of Lexington, Mass.; and as a Programmer and Systems Analyst at Massachusetts General Hospital in Boston. He graduated with a B.S. in biology from Boston College.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160728005475/en/
Illumina, Inc.
Investors:
Rebecca Chambers,
858-255-5243
[email protected]
or
Media:
Eric
Endicott, 858-882-6822
[email protected]
Source: Illumina, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GRAIL Presents New Data on Galleri® and Its Methylation Platform at the Annual American Association for Cancer Research (AACR) Meeting
- Oracle NetSuite Supercharges the Suite with Expansion of Generative AI Capabilities
- FTK Promotes Desiray Taylor to VP, Human Resources
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!